Publications by authors named "Ralph Link"

Claim this Profile
E
Elevated liver enzymes predict morbidity and mortality despite antiviral cure in patients with chronic hepatitis C: Data from the German Hepatitis C-Registry.
Frank Tacke, Hartwig Klinker, Klaus H W Boeker, Uta Merle, Ralph Link

Hepatol Commun· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weight Gain after Interferon-Free Treatment of Chronic Hepatitis C-Results from the German Hepatitis C-Registry (DHC-R).
Bernhard Schlevogt, Klaus H W Boeker, Stefan Mauss, Hartwig Klinker, Renate Heyne, Ralph Link

Biomedicines· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of gender on cytokine induced depression and treatment: Gender aspects of IFN-α-induced depression.
Susanne Sarkar, Jonas Kemper, Rahul Sarkar, Loni Brants, Astrid Friebe, Ralph Link

J Affect Disord· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Only partial improvement in health-related quality of life after treatment of chronic hepatitis C virus infection with direct acting antivirals in a real-world setting-results from the German Hepatitis C-Registry (DHC-R).
Valerie Ohlendorf, Arne Schäfer, Stefan Christensen, Renate Heyne, Uwe Naumann, Ralph Link

J Viral Hepat· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes and Costs of Treating Hepatitis C Patients in the Era of First Generation Protease Inhibitors - Results from the PAN Study.
Jona T Stahmeyer, Siegbert Rossol, Florian Bert, Klaus H W Böker, Harald-Robert Bruch, Ralph Link

PLoS One· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World Setting.
Steffen B Wiegand, Benjamin Heidrich, Simone Susser, Magdalena Rogalska-Taranta, Jörg Petersen, Ralph Link

PLoS One· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of naïve patients with chronic hepatitis C genotypes 2 and 3 with pegylated interferon alpha and ribavirin in a real world setting: relevance for the new era of DAA.
Benjamin Heidrich, Steffen B Wiegand, Peter Buggisch, Holger Hinrichsen, Ralph Link, Hartwig Klinker

PLoS One· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Escitalopram for the prevention of peginterferon-α2a-associated depression in hepatitis C virus-infected patients without previous psychiatric disease: a randomized trial.
Martin Schaefer, Rahul Sarkar, Viola Knop, Susanne Effenberger, Astrid Friebe, Ralph Link

Ann Intern Med· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus interferon and ribavirin for patients with chronic hepatitis C and failure of previous interferon-alpha therapy.
Wulf O Böcher, Marcus Schuchmann, Ralph Link, Heribert Hillenbrand, Fareed Rahman

Liver Int· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis